With the addition of 12.5 mg and 15 mg vials, all approved doses of Zepbound will be available in single-dose vials for $499/month or less, regardless of ...

Starting July 7, 2025, the two highest doses of Zepbound will be available for a flat price of $499 per month, with shipments ...

With the addition of 12.5 mg and 15 mg vials, all approved doses of Zepbound will be available in single-dose vials for $499 /month or less, regardless of insurance ...

Eli Lilly expands Zepbound access with flat-rate pricing and new vial options, supporting wider obesity treatment access ...

India has officially approved and launched Mounjaro (tirzepatide), a groundbreaking injectable medication for the treatment of Type 2 diabetes and obesity. Developed by Eli Lilly and Company, the drug ...

Tirzepatide has been approved by the ... or 15 mg per 0.5 mL in single-dose pen or single-dose vial. Zepbound is a prescription medicine. For more information, call 1-800-LillyRx (1-800-545-5979 ...

Mounjaro is the brand name of tirzepatide, which is also approved ... Right now, with her lower dose, she pays about $200 for a 2-mL vial that lasts her about five months. Compared to weight ...

has seen its recent launch of single-use tirzepatide vials shift patient practices toward its weight loss drug Zepbound. According to InvestingPro analysis, Lilly maintains a "GREAT" financial ...